156 related articles for article (PubMed ID: 6732835)
1. Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.
Spector T; Jones TE; LaFon SW; Nelson DJ; Berens RL; Marr JJ
Biochem Pharmacol; 1984 May; 33(10):1611-7. PubMed ID: 6732835
[TBL] [Abstract][Full Text] [Related]
2. Guanosine 5'-monophosphate reductase from Leishmania donovani. A possible chemotherapeutic target.
Spector T; Jones TE
Biochem Pharmacol; 1982 Dec; 31(23):3891-7. PubMed ID: 7159467
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and mechanism of action of formycin B in Leishmania.
Rainey P; Santi DV
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
[TBL] [Abstract][Full Text] [Related]
4. Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism.
Marr JJ; Berens RL; Nelson DJ; Krenitsky TA; Spector T; LaFon SW; Elion GB
Biochem Pharmacol; 1982 Jan; 31(2):143-8. PubMed ID: 7073876
[TBL] [Abstract][Full Text] [Related]
5. Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents.
Spector T; Berens RL; Marr JJ
Biochem Pharmacol; 1982 Jan; 31(2):225-9. PubMed ID: 7037007
[TBL] [Abstract][Full Text] [Related]
6. Inosine analogs. Their metabolism in mouse L cells and in Leishmania donovani.
LaFon SW; Nelson DJ; Berens RL; Marr JJ
J Biol Chem; 1985 Aug; 260(17):9660-5. PubMed ID: 4019491
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
Nelson DJ; Bugge CJ; Elion GB; Berens RL; Marr JJ
J Biol Chem; 1979 May; 254(10):3959-64. PubMed ID: 438170
[TBL] [Abstract][Full Text] [Related]
8. Biochemical genetic analysis of formycin B action in Leishmania donovani.
Robinson N; Kaur K; Emmett K; Iovannisci DM; Ullman B
J Biol Chem; 1984 Jun; 259(12):7637-43. PubMed ID: 6203896
[TBL] [Abstract][Full Text] [Related]
9. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
Neal RA; Croft SL; Nelson DJ
Trans R Soc Trop Med Hyg; 1985; 79(1):122-8. PubMed ID: 3992630
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of pyrazolopyrimidines in Leishmania donovani.
Looker DL; Marr JJ; Berens RL
J Biol Chem; 1986 Jul; 261(20):9412-5. PubMed ID: 2424909
[TBL] [Abstract][Full Text] [Related]
11. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
Looker DL; Martinez S; Horton JM; Marr JJ
J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
Berman JD; Rainey P; Santi DV
J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
[TBL] [Abstract][Full Text] [Related]
13. Activity of purine analogs against Leishmania tropica within human macrophages in vitro.
Berman JD; Lee LS; Robins RK; Revankar GR
Antimicrob Agents Chemother; 1983 Aug; 24(2):233-6. PubMed ID: 6638989
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.
Berens RL; Marr JJ; Looker DL; Nelson DJ; LaFon SW
J Infect Dis; 1984 Oct; 150(4):602-8. PubMed ID: 6436394
[TBL] [Abstract][Full Text] [Related]
15. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
Nolan LL; Berman JD; Giri L
Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a mutant Leishmania donovani deficient in adenosine kinase activity.
Iovannisci DM; Ullman B
Mol Biochem Parasitol; 1984 Jun; 12(2):139-51. PubMed ID: 6090896
[TBL] [Abstract][Full Text] [Related]
17. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
Berman JD
J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
[No Abstract] [Full Text] [Related]
18. Comparative metabolism of a new antileishmanial agent, allopurinol riboside, in the parasite and the host cell.
Nelson DJ; LaFon SW; Elion GB; Marr JJ; Berens RL
Adv Exp Med Biol; 1979; 122B():7-12. PubMed ID: 546162
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of formycin. Formation of formycin from formycin B.
Ochi D; Yashima S; Eguchi Y
J Antibiot (Tokyo); 1975 Dec; 28(12):965-73. PubMed ID: 1206009
[TBL] [Abstract][Full Text] [Related]
20. Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells.
Mehta KD; Gupta RS
Biochem Biophys Res Commun; 1985 Jul; 130(2):910-7. PubMed ID: 2992490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
